ProQR Announces Webcast of Presentation at the Upcoming Stifel 2022 Healthcare Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- LEIDEN, Netherlands & CAMBRIDGE, Mass., November 3, 2022 -- ProQR Therapeutics N.V. November 03, 2022
ProQR to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. June 28, 2022
ProQR Announces Strategic Changes to the Management Team and Key New Hires Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. December 13, 2018
ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. August 11, 2021
ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014 Press release LEIDEN, Netherlands, Feb. 26, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. February 26, 2015
ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- May 09, 2023
ProQR Appoints John Maraganore, PhD, as Strategic Advisor to the Supervisory Board Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. March 07, 2022
ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. September 28, 2023
ProQR In-licenses Worldwide Rights to Ophthalmology Drug Candidate from Ionis Pharmaceuticals Press release ProQR receives exclusive worldwide license for IONIS-RHO-2.5Rx, now QR-1123, for autosomal dominant retinitis pigmentosa (adRP), a rare inherited form of blindness with no approved therapy October 29, 2018
ProQR to Present Axiomer RNA Editing Platform Technology at RNA Editing Summit Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. April 04, 2022